Prostate Cancer International is
for 2011 by Great NonProfits
The value of regular testing of increasingly elderly men and women for risk of cancer is controversial. However, a new paper in the Archives of Internal Medicine has certainly added to our knowledge of just how widespread such testing may be … at least in the USA.
Filed under: Diagnosis, Management, Risk | Tagged: elderly, recommendation, screening, testing | 9 Comments »
We aren’t sure exactly what this adds to the recent conversations, but Gallup, the market research firm, has just provided results of a poll that asked 1,102 upstanding American adults for their opinions about cancer screening.
Filed under: Diagnosis, Risk | Tagged: Gallup, opinion, perception, public, screening | 9 Comments »
The October issue of the Canadian Journal of Urology contains an interesting and thorough review of the available data on the value of screening for prostate cancer as seen by a group including urologists, urologic oncologists, medical oncologists, radiation oncologists, and a highly regarded primary care physician.
Filed under: Diagnosis, Risk | Tagged: mortality, PSA, risk, screening, testing | Leave a Comment »
The debate over the merits and risks of widespread screening for prostate cancer using the PSA test is hardly confined to the USA. A new article (in German) in the journal Urologie A addresses exactly the same issues as have recently received so much attention here in the States.
Filed under: Diagnosis, Risk | Tagged: Diagnosis, mortality, PSA, risk, screening | 1 Comment »
On November 8, the American Urological Asociation (AUA) issued its full, formal comment letter on the US Preventive Services Task Force (USPSTF)’s draft recommendation of a “D” grade for the use of PSA screening in healthy men with no symptoms of prostate cancer. The AUA also issued a formal statement for the media.
Filed under: Diagnosis, Risk | Tagged: AUA, Diagnosis, PSA, risk, screening, USPSTF | 3 Comments »
Larry Axmaker is an 8-year prostate cancer survivor and very happy he had regular PSA screenings!
Filed under: Diagnosis, Risk | Tagged: recommendation, screening, testing, USPSTF | 1 Comment »
Ten members of the Prostate Cancer Roundtable have today submitted a joint letter to the U.S. Preventive Services Task Force commenting on the recent draft recommendation of a “D” grade for use of the PSA test in screening for prostate cancer among men who do not have symptoms that are highly suspicious for prostate cancer, [...]
Filed under: Diagnosis, Risk | Tagged: PSA testing, risk, screening, USPSTF | 1 Comment »
This week’s issue issue of the New England Journal of Medicine includes four perspective articles on the recent draft recommendation about PSA screening issued by the U.S. Preventive Services Task Force (USPSTF).
Filed under: Diagnosis, Risk | Tagged: PSA, recommendation, screening, testing, USPSTF | 5 Comments »
The following editorial commentary related to the USPSTF recommendation was published on Friday, October 13, 2011 on the UroToday web site and is reproduced here with the permission of UroToday. The commentary was written by Alan Wein, MD,
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: PSA, recommendation, risk, screening, testing, USPSTF | 6 Comments »
The “New” Prostate Cancer InfoLink has replicated below, in its entirety, a media release issued early this morning by the Prostate Cancer Foundation. We believe that this is precisely the correct response to the new USPSTF recommendation: acknowledgement of the realities of the USPSTF’s factually accurate recommendation and the recognition by the USPSTF that PSA [...]
Filed under: Diagnosis, Management, Risk | Tagged: screening, USPSTF, testing, Prostate cancer Foundation, PCF | 5 Comments »
There is a critically important portion of the USPSTF recommendation that few people seem to be noticing or acknowledging. It reads as follows:
Filed under: Diagnosis, Management, Risk | Tagged: risk, screening, testing | 3 Comments »
Whatever we may think individually about the recent decision by the U.S. Preventive Services Task Force to recommend against the use of PSA testing as a means of “screening” for risk of prostate cancer, we would be wise to understand that at the heart of this decision is poor science.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: PSA, risk, screening, survival, USPSTF | 29 Comments »
According to an article in today’s New York Times, the United States Preventive Services Task Force (USPSTF) has chosen to advise against routine use of the PSA test to screen healthy men for prostate cancer because “the test does not save lives and often leads to more tests and treatments that needlessly cause pain, impotence [...]
Filed under: Diagnosis, Risk | Tagged: Diagnosis, risk, screening | 10 Comments »
Between 1981 and 1983 researchers collected and stored blood samples from 4,500 men in Copenhagen, Denmark, as part of the Copenhagen City Heart Study. These blood samples had been carefully stored — and otherwise unused — for nearly 30 years. In 2010, a new research team decided to measure the PSA levels in these blood [...]
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: Diagnosis, long-term, mortality, PSA, risk, screening | 5 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site